CANTATA EvaluatorSM for CI

Methodology  

New CE: Go  
Company Information
Symbol: CI
Company: The Cigna Group
Company Description: The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Stock is Optionable: Yes
SEC Filings Edgar Online
General Due Diligence and Earnings Date Info: Due Diligence
Exchange: NYSE
CANTATA Evaluation for 03/28/2024
CE Zone
Time- liness CET CEF CE* Industry Industry
Rank
Industry
Score
4-3 0/2 7.68 / 7 5.61 / 11 13.29 /18 Healthcare Plans 69 / 215 88 / 100
*Excluding Timeliness points
Timeliness
Item Data Points Maximum
Possible
1
Currently listed on CwH, DB, HTF or SQZ watchlists
0 1
2
Broke out in last 5 days and within 5% of BoP
0 1
 
Total Timeliness Points
0 2
CANTATA Evaluation Technical (CET)
Item Data Points Maximum
Possible
1 Price relative to 50 and 200 day moving averages; 50 day relative to 200 day moving average
Last Close: $ 363.19
50 dma $ 333.47
200 dma $ 0.00
2.53 3
2 Relative Strength Rank
RS 80
2.42 3
3 Rank in Industry
Rank in Industry 5
# of stocks in Industry 604
0.73 1
4 Price relative to 52 week high
% off 52 week high 0.69 %
1.00 1
5 Up/Down Ratio
Up/Down Ratio: 2.0
1.00 1
  Miscellaneous Technical Data (no points assigned)
Beta 0.520
PE (vs. S&P 500) 17.200 (0.85 x)
5yr PE low - high 8.310 - 21.620
n/a n/a
  Total Technical Points (CET) 7.68 9
CANTATA Evaluation Fundamentals (CEF)
1 Quarter over Quarter Earnings Growth
09/30/23 4.739 vs. 17.459 [ -72.86 %]
06/30/23 4.918 vs. 4.890 [ 0.57 %]
03/31/23 4.237 vs. 3.726 [ 13.71 %]
12/31/22 3.829 vs. 3.387 [ 13.05 %]
0.01 1
2 Positive Quarterly Earnings 1.00 1
3 Quarterly Earnings Growth Acceleration 0.30 1
4 Year over Year Earnings Growth Rates
12/31/22 21.299 [ 35 %]    
12/31/21 15.735 [ -31 %]    
12/31/20 22.959 [ 71 %]    
12/31/19 13.438 [ 28 %]    
12/31/18 10.523 [ 0 %]    
0.70 1
5 Quarter over Quarter Sales Growth Rates
09/30/23 49048.000 vs. 134765.000 [ -63.6 %]
06/30/23 48586.000 vs. 45478.000 [ 6.83 %]
03/31/23 46517.000 vs. 44006.000 [ 5.71 %]
12/31/22 45751.000 vs. 45688.000 [ 0.14 %]
0.11 1
6 Quarterly Sales Growth Rate Acceleration 0.60 1
7 Forward Earnings Growth Rates
Est. EPS growth current Fiscal Yr to next 13.900 %
Est. EPS Growth Next Fiscal Yr to Following 11.700 %
0.00 1
8 Institutional Ownership
Number of Institutional Owners 1978.000
Net shares purchased MRQ ('000) -4198.000
Institutional Ownership Details  
0.50 1
9 Return on Equity (ROE)
ROE - TTM 11.77 %
0.69 1
10 Cash Flow:
Cash from operations MRQ 2826.000
Earnings TTM 5211.589934
Cash from operations TTM 12445.000
Cash flow above/below earnings TTM 1.39
1.00 1
11 Net Margins
12/31/22 3.700%
12/31/21 3.100%
12/31/20 5.300%
0.70 1
  Miscelleneous Fundamental Data (no points assigned)
Financial Overview
Long term debt to equity 61.500 %  
Current Fiscal Year End 12/31/23  
Yearly Sales ('000) 12/31/22 180516.000
      12/31/21 174078.000
      12/31/20 160197.000
      12/31/19 153566.000
      12/31/18 48446.000
n/a n/a
  Total Fundamental Points (CEF) 5.61 11
  Total CANTATA Evaluation Points 13.29 20